REVIVA PHARMACEUTICALS HOLDINGS CEO Laxminarayan Bhat's 2021 pay jumps 142% to $600K
REVIVA PHARMACEUTICALS HOLDINGS reports 2021 executive compensation
By ExecPay News
Published: October 11, 2022
REVIVA PHARMACEUTICALS HOLDINGS reported fiscal year 2021 executive compensation information on October 11, 2022.
In 2021, three executives at REVIVA PHARMACEUTICALS HOLDINGS received on average a compensation package of $513K, a 354% increase compared to previous year.
Average pay of disclosed executives at REVIVA PHARMACEUTICALS HOLDINGS
Laxminarayan Bhat, Chief Executive Officer, received $600K in total, which increased by 142% compared to 2020. 67% of Bhat's compensation, or $400K, was in salary. Bhat also received $200K in bonus.
Marc Cantillon, Chief Medical Officer, received a compensation package of $502K, which increased by 990% compared to previous year. 77% of the compensation package, or $385K, was in salary.
Narayan Prabhu, Chief Financial Officer, earned $437K in 2021, a 865% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on October 11, 2022.